離開
進入《TAIPEI TIMES》 Nobel prize goes to mRNA COVID-19 vaccine researchers
Thomas Perlmann, member of the Nobel Assembly at the Karolinska Institute, speaks in front of an image of this year’s winners of the Nobel Prize in Physiology or Medicine, Katalin Kariko of Hungary and Drew Weissman of the US, at the Karolinska Institute in Stockholm yesterday. Photo: AFP
/ AFP, STOCKHOLM
Katalin Kariko and Drew Weissman yesterday won the Nobel Prize in Medicine for work on messenger RNA （mRNA） technology that paved the way for groundbreaking COVID-19 vaccines.
The pair, who had been tipped as favorites, “contributed to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times,” the jury said.
The WHO declared COVID-19 a pandemic in March 2020 and the mRNA vaccines were approved for use in December that year. Billions of doses have been administered around the world since then.
Together with other COVID-19 vaccines, they “have saved millions of lives and prevented severe disease in many more,” the jury said.
Longstanding colleagues at the University of Pennsylvania in the US, adjunct professor of neurosurgery Kariko, 68, and Roberts family professor in vaccine research Weissman, 64, have won a slew of awards for their research. They include the prestigious Lasker Award in 2021, often seen as a precursor to the Nobel.
In honoring the pair this year, the Nobel committee in Stockholm broke with its usual practice of honoring decades-old research, after ensuring it has stood the test of time.
While the prizewinning research dates back to 2005, the first vaccines to use the mRNA technology were those made by Pfizer/BioNTech and Moderna against COVID-19.
Unlike traditional vaccines that use weakened virus or a key piece of the virus’ protein, mRNA vaccines provide the genetic molecules that tell cells what proteins to make, which simulates an infection and trains the immune system for when it encounters the real virus.
The idea was first demonstrated in 1990, but it was not until the mid-2000s that Weissman, of the US, and Hungarian-born Kariko developed a technique to control a dangerous inflammatory response seen in animals exposed to these molecules, opening the way to develop safe human vaccines.
The honor is particularly sweet for Kariko, the 13th woman to win the medicine prize, who toiled in obscurity for years and struggled to convince her superiors of the need for mRNA research.
Speaking to Swedish Radio, she said her late mother always had faith in her, listening to the Nobel prize announcements “year after year” in the hopes of hearing her daughter’s name called out.
“Unfortunately, five years ago she passed at the age of 89. She might be listening from above,” Kariko said.
Nobel Assembly secretary-general Thomas Perlmann called Kariko “an extraordinary and unusual scientist” who “resisted any temptation” to do “something easier.”
Weissman told Swedish Radio he heard the news from Kariko, who received the call from the jury first.
“We weren’t sure if somebody was playing a prank on us,” he said, adding that he would “probably go out with my family and have a nice dinner” to celebrate.
The pair’s mRNA technology is now being used to develop other treatments for diseases and illnesses such as cancer, influenza and heart failure.
They are to receive their Nobel prize, consisting of a diploma, a gold medal and US$1 million, in Stockholm on Dec. 10.
新聞來源：TAIPEI TIMES
